Summary
Derivatives of dihydro-digitoxin (DHD) were studied in the search for a glycoside with a primarily extra-renal clearance and a faster elimination rate than digitoxin. The positive inotropic doses of the derivatives of DHD were higher than those of digitoxin and digoxin. There was no significant difference in the therapeutic margin. After injection of 3H-digoxin in unaesthetized cats, no metabolites were found in the serum which did not bind with the antibody used for the RIA. After injection of 3H-digitoxin, and its derivatives, the radioactivity was cleared from the serum at a much lower rate than the concentrations assayed by RIA. The metabolites which did not bind to the digitoxin antibody were hydrophilic and had a low protein binding. Digitoxin-bisdigitoxoside (Dt-2) determined by RIA rapidly disappeared from the serum. The radioactivity remaining after 24 h was eliminated with a half-life of 219 h. Ten min after injection of DHD the serum contained no unchanged DHD, but 36% digitoxin suggesting that the reduction of digitoxin to DHD is reversible and that the conversion of DHD to Dt-2 is the rate limiting step in the metabolism of digitoxin. The total body clearance of digitoxin, its metabolites and derivatives determined by RIA increased in the order DHD-oxime ⩽ digitoxin > DHD ⩽ DHD-acetyloxime < DHD-methyloxime. The clearance and the elimination rate of DHD-methyloxime were significantly higher than those of digitoxin (P = 0.05).
Similar content being viewed by others
References
Betzien G, Dietmann K, Schaumann W (1980) Resorption, renale und extrarenale Clearance von Digoxin. Herz/Kreisl 12:115–120
Bolton GR, Powell W (1982) Plasma kinetics of digoxin in the cat. Am J Vet Res 43:1994–1999
Flasch H, Heinz N, Petersen R (1977) Affinität von polaren Digoxin- und Digitoxin-Metaboliten zu Digoxin- und Digitoxin-Antikörpern. Arzneimittelforsch 27:649–653
Graves PE, Fenster PE, MacFarland RT, Marcus FI, Perrier D (1984) Kinetics of digitoxin and the bis- and monodigitoxosides of digitoxigenin in normal subjects. Clin Pharmacol Ther 36:601–606
Haberland G, Maerten G (1969) Spezifischer Deuterium- und Tritium-Austausch in Cardenoliden und Cardenolidglykosiden. Naturwissenschaften 56:516
Hempelmann FW, Heinz N (1978) Lipophilie und Proteinbindung bei Cardenoliden. Arzneimittelforsch 28:2185–2187
Kroneberg G, Schaumann W, Stoepel K (1962) Wirkungsdauer und enterale Resorption von Digitoxigenin-monodigitoxosid (Dt 21). Naunyn-Schmiedeberg's Arch Exp Pathol Pharmakol 201:91–98
Perrier D, Mayersohn M, Marcus FI (1977) Clinical pharmacokinetics of digitoxin. Clin Pharmacol 2:292–311
Petersen R, Flasch H, Heinz N (1977) Darstellung und Eigenschaften einiger Glukuronide und Sulfate von Cardenoliden und Cardenolid-glykosiden. Arzneimittelforsch 27:642–649
Repke K (1959) Die Bis- und Mono-digitoxoside des Digitoxigenins und Digoxigenins: Metaboliten des Digitoxins. Naunyn-Schmiedeberg's Arch Exp Pathol Pharmakol 237:155–170
Repke K, Herrmann I (1962) Speziesunterschiede in der Geschwindigkeit der fermentativen Inaktivierung von Digitoxin. Naunyn-Schmiedeberg's Arch Exp Pathol Pharmakol 243:331–333
Schaumann W, Kaufmann B (1982) Explanation of the biologically implausible correlation between distribution volume and total body clearance in an open two-compartment model. Int J Clin Pharmacol Ther Toxicol 20:508–510
Schmoldt A, Herzberg W, Van Ackeren H, Benthe HF (1983) On the cleavage of digitoxin (Dt-3) by human liver microsomes. Naunyn-Schmiedeberg's Arch Pharmacol 322:R 110
Schmoldt A, Rohloff C (1978) Dehydro-digitoxosides of digitoxigenin: formation and importance for the digitoxin metabolism in the rat. Naunyn-Schmiedeberg's Arch Pharmacol 305:167–172
v. Wartburg A, Kalberger F, Rutschmann J (1965) Tritium-labelled cardiac glycosides: digoxin (12 Alpha-3H). Biochem Pharmacol 14:1883–1889
Weidler DJ, Jallad NS, Movahhed HS, Sakmar E, Wagner JG (1978) Pharmacokinetics of digoxin in the cat and comparisons with man and the dog. Res Commun Chem Pathol Pharmacol 19:57–66
Author information
Authors and Affiliations
Additional information
Send offprint requests to W. Schaumann at the above address
Rights and permissions
About this article
Cite this article
Bauer, I., Neubert, P. & Schaumann, W. Pharmacodynamics, pharmacokinetics and metabolism of digitoxin and derivatives in cats. Naunyn-Schmiedeberg's Arch Pharmacol 335, 469–475 (1987). https://doi.org/10.1007/BF00165565
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF00165565